D
Amylyx Pharmaceuticals, Inc. AMLX
$3.63 -$0.045-1.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Total Cash And Short-Term Investments 176.50M 234.40M 309.81M 373.29M 371.36M
Total Receivables 547.00K 1.73M 4.19M 20.65M 40.55M
Inventory -- -- -- -- 38.32M
Prepaid Expenses 12.38M 9.14M 12.72M 16.59M 14.43M
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 189.43M 245.26M 326.72M 410.53M 464.67M

Total Current Assets 189.43M 245.26M 326.72M 410.53M 464.67M
Net Property, Plant & Equipment 2.73M 3.53M 4.24M 5.71M 6.41M
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 1.47M 1.92M 1.20M 1.21M 46.38M
Total Assets 193.63M 250.71M 332.16M 417.46M 517.45M

Total Accounts Payable 2.94M 1.49M 4.96M 21.45M 22.06M
Total Accrued Expenses 23.95M 50.46M 62.76M 67.87M 57.72M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 1.52M 1.97M 2.37M 2.31M 2.26M
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 28.41M 53.92M 70.08M 91.64M 82.04M

Total Current Liabilities 28.41M 53.92M 70.08M 91.64M 82.04M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 463.00K 595.00K 772.00K 1.38M 1.98M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 28.87M 54.51M 70.85M 93.02M 84.02M

Common Stock & APIC 771.55M 764.71M 757.85M 748.26M 738.18M
Retained Earnings -606.69M -569.15M -496.44M -423.74M -304.95M
Treasury Stock & Other -92.00K 641.00K -97.00K -77.00K 197.00K
Total Common Equity 164.77M 196.20M 261.31M 324.44M 433.43M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 164.77M 196.20M 261.31M 324.44M 433.43M
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 164.77M 196.20M 261.31M 324.44M 433.43M

Weiss Ratings